Development and Validation of RP-HPLC for Estimation of Brexpiprazole in Bulk Drugs

Authors

  • Komal Kashinath Andhale JSPM’s Jayawantrao Sawant College of Pharmacy and Research, Pune, Maharashtra, India.
  • S. U. Puri JSPM’s Jayawantrao Sawant College of Pharmacy and Research, Pune, Maharashtra, India.
  • K. S. Belsare JSPM’s Jayawantrao Sawant College of Pharmacy and Research, Pune, Maharashtra, India.
  • P. A. Nitnaware JSPM’s Jayawantrao Sawant College of Pharmacy and Research, Pune, Maharashtra, India.

Keywords:

Brexpiprazole, Reverse-phase high-performance liquid chromatography, Validation

Abstract

A simple, rapid, accurate, and sensitive method was developed for quantitative analysis of Brexpiprazole in bulk dosage form using reverse phase high-performance liquid chromatography with UV detection. The chromatography separation was achieved on Kromasil -C18, (250 mm × 4.6 mm i.d., 5 μm particle size), at column temperature 25°C ± 2, in the isocratic mobile phase mode using acetonitrile 5% ortho-phosphoric acid: water (60:40 v/v) at a flow rate of 1.0 mL/min. The determination was performed using waters HPLC with UV detector set at 216 nm. Samples were prepared with diluent methanol, and the volume injected was 20 μL. The retention time for brexpiprazole was 3.89 min. The analytical curve was linear (r2=0.99994) over a wide concentration range (0.51–7.50 μg/mL). The presence of components of the bulk did not interfere in the results of the analysis. The method showed adequate precision with a relative standard deviation <2%.

Downloads

Download data is not yet available.

Downloads

Published

2023-03-13

How to Cite

Komal Kashinath Andhale, S. U. Puri, K. S. Belsare, & P. A. Nitnaware. (2023). Development and Validation of RP-HPLC for Estimation of Brexpiprazole in Bulk Drugs. Asian Pacific Journal of Health Sciences, 10(1), 52–73. Retrieved from https://apjhs.com/index.php/apjhs/article/view/3036